News and Insights
Press release Novo Nordisk
HemoCue enters partnership with Novo Nordisk to improve point-of-care diagnostic testing for children with type 1 diabetes in low- and middle-income countries.
It has always been the HemoCue way to conduct our business with integrity, fairness, and transparency. Together with our passion for accuracy and attention to detail, this has made us a trusted partner in global health – providing point of care testing.
Hemocue 40 years
On October 26, 2022, HemoCue celebrated 40 years since the first sale of a hemoglobin measuring device. Our founders had a dream to provide a safe, effective, lab-accurate hemoglobin measurement device. Today, our products are used on four patients every second with 140 million microcuvettes sold each year. And we are just getting started!